Conifer Management

Conifer Management is a private investment firm and family office based in New York that is widely recognized for its concentrated, long-term investment strategy within the life sciences and biotechnology sectors. The firm is most notable for its significant and enduring ownership stake in Sarepta Therapeutics, where it has historically held approximately 10% of the company's outstanding shares. As a sophisticated institutional investor, Conifer Management often engages deeply with its portfolio companies, focusing on high-conviction opportunities in genetic medicine and orphan diseases. While it operates primarily as a financial entity rather than a drug developer, its influence and capital have been instrumental in the growth of major biotech players.